Literature DB >> 20878720

Principal pathogenetic components and biological endophenotypes in autism spectrum disorders.

Roberto Sacco1, Paolo Curatolo, Barbara Manzi, Roberto Militerni, Carmela Bravaccio, Alessandro Frolli, Carlo Lenti, Monica Saccani, Maurizio Elia, Karl-Ludvig Reichelt, Tiziana Pascucci, Stefano Puglisi-Allegra, Antonio M Persico.   

Abstract

Autism is a complex neurodevelopmental disorder, likely encompassing multiple pathogenetic components. The aim of this study is to begin identifying at least some of these components and to assess their association with biological endophenotypes. To address this issue, we recruited 245 Italian patients with idiopathic autism spectrum disorders and their first-degree relatives. Using a stepwise approach, patient and family history variables were analyzed using principal component analysis ("exploratory phase"), followed by intra- and inter-component cross-correlation analyses ("follow-up phase"), and by testing for association between each component and biological endophenotypes, namely head circumference, serotonin blood levels, and global urinary peptide excretion rates ("biological correlation phase"). Four independent components were identified, namely "circadian & sensory dysfunction," "immune dysfunction," "neurodevelopmental delay," and "stereotypic behavior," together representing 74.5% of phenotypic variance in our sample. Marker variables in the latter three components are positively associated with macrocephaly, global peptiduria, and serotonin blood levels, respectively. These four components point toward at least four processes associated with autism, namely (I) a disruption of the circadian cycle associated with behavioral and sensory abnormalities, (II) dysreactive immune processes, surprisingly linked both to prenatal obstetric complications and to excessive postnatal body growth rates, (III) a generalized developmental delay, and (IV) an abnormal neural circuitry underlying stereotypies and early social behaviors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20878720     DOI: 10.1002/aur.151

Source DB:  PubMed          Journal:  Autism Res        ISSN: 1939-3806            Impact factor:   5.216


  33 in total

1.  Examining autism spectrum disorders by biomarkers: example from the oxytocin and serotonin systems.

Authors:  Elizabeth Hammock; Jeremy Veenstra-VanderWeele; Zhongyu Yan; Travis M Kerr; Marianna Morris; George M Anderson; C Sue Carter; Edwin H Cook; Suma Jacob
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2012-05-26       Impact factor: 8.829

2.  Anti-brain antibodies are associated with more severe cognitive and behavioral profiles in Italian children with Autism Spectrum Disorder.

Authors:  I S Piras; L Haapanen; V Napolioni; R Sacco; J Van de Water; A M Persico
Journal:  Brain Behav Immun       Date:  2014-01-03       Impact factor: 7.217

3.  Comorbidity in Atopic Dermatitis.

Authors:  Eric L Simpson
Journal:  Curr Dermatol Rep       Date:  2012-03-01

4.  Autism gene variant causes hyperserotonemia, serotonin receptor hypersensitivity, social impairment and repetitive behavior.

Authors:  Jeremy Veenstra-VanderWeele; Christopher L Muller; Hideki Iwamoto; Jennifer E Sauer; W Anthony Owens; Charisma R Shah; Jordan Cohen; Padmanabhan Mannangatti; Tammy Jessen; Brent J Thompson; Ran Ye; Travis M Kerr; Ana M Carneiro; Jacqueline N Crawley; Elaine Sanders-Bush; Douglas G McMahon; Sammanda Ramamoorthy; Lynette C Daws; James S Sutcliffe; Randy D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

5.  Homogeneous Subgroups of Young Children with Autism Improve Phenotypic Characterization in the Study to Explore Early Development.

Authors:  Lisa D Wiggins; Lin H Tian; Susan E Levy; Catherine Rice; Li-Ching Lee; Laura Schieve; Juhi Pandey; Julie Daniels; Lisa Blaskey; Susan Hepburn; Rebecca Landa; Rebecca Edmondson-Pretzel; William Thompson
Journal:  J Autism Dev Disord       Date:  2017-11

Review 6.  Biomarkers in autism spectrum disorder: the old and the new.

Authors:  Barbara Ruggeri; Ugis Sarkans; Gunter Schumann; Antonio M Persico
Journal:  Psychopharmacology (Berl)       Date:  2013-10-06       Impact factor: 4.530

7.  Mental health comorbidity in patients with atopic dermatitis.

Authors:  Pouya Yaghmaie; Caroline W Koudelka; Eric L Simpson
Journal:  J Allergy Clin Immunol       Date:  2012-12-13       Impact factor: 10.793

Review 8.  The serotonin system in autism spectrum disorder: From biomarker to animal models.

Authors:  C L Muller; A M J Anacker; J Veenstra-VanderWeele
Journal:  Neuroscience       Date:  2015-11-11       Impact factor: 3.590

9.  Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression, in MAO A-deficient mice.

Authors:  Marco Bortolato; Sean C Godar; Simone Tambaro; Felix G Li; Paola Devoto; Marcelo P Coba; Kevin Chen; Jean C Shih
Journal:  Neuropharmacology       Date:  2013-07-16       Impact factor: 5.250

10.  Altered cytokine and BDNF levels in autism spectrum disorder.

Authors:  S Ricci; R Businaro; F Ippoliti; V R Lo Vasco; F Massoni; E Onofri; G M Troili; V Pontecorvi; M Morelli; M Rapp Ricciardi; T Archer
Journal:  Neurotox Res       Date:  2013-04-19       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.